Skip to main content
FranchiseInsights
TerryWhite Chemmart logo
Brand Intelligence Report

TerryWhite Chemmart

The community pharmacy franchise balancing clinical trust with retail margin.

Independent, publicly sourced franchise intelligence for prospective buyers.

Want to see the full depth first? Read our free McDonald's sample report →

How much does a TerryWhite Chemmart franchise cost in Australia?

The total initial investment for a TerryWhite Chemmart franchise in Australia is AUD $250,000–$600,000 (total entry cost including fit-out and stock), based on publicly available figures.

The full report breaks down every cost category and how controllable each one is.

What are TerryWhite Chemmart's franchise fees and royalties?

TerryWhite Chemmart's published fees — royalty: 0% royalty on revenue; marketing levy: 0% — marketing funded through supplier rebates and group arrangements.

The full report maps the complete fee architecture and how each fee behaves as revenue moves.

Is a TerryWhite Chemmart franchise a good investment?

Independent analysis gives TerryWhite Chemmart a weighted risk score of 6.1 out of 10 — Elevated Risk. That is a finding, not a recommendation: suitability depends on the buyer's capital, experience, and risk tolerance.

What drives the score, and which buyer profiles the model suits, is detailed across five risk dimensions in the full report.

Overall Risk Score

6.1

out of 10

Risk Classification

Elevated Risk

Highest Risk Area

Financial Risk

8.3 / 10

Report Overview

TerryWhite Chemmart is one of Australia's largest community pharmacy franchises, operating approximately 520 locations nationally. Founded in 1994 and headquartered in Brisbane, the brand combines professional health services — dispensing, vaccinations, health screenings — with competitive retail pricing on front-of-shop products. With a 0% royalty and 0% marketing levy model, the franchise attracts pharmacists seeking brand leverage without ongoing percentage-based fees. This report delivers a comprehensive, independent analysis of the TerryWhite Chemmart franchise opportunity.

Weighted risk score with full rationale across 5 dimensions
7-section institutional-grade intelligence report
Detailed cost and fee architecture covering entry to operation
5 regret drivers with severity ratings and onset timing
4 profit sensitivity scenarios modelling margin outcomes
30+ commercially intelligent due diligence questions
Suitability analysis: who thrives and who struggles
Benchmark comparison against service, QSR, and low-capex franchise categories

System Snapshot

Free preview
CategoryCommunity pharmacy — dispensing, health services, and retail
Founded1994
Parent CompanyEBOS Group (ASX-listed, acquired TerryWhite Chemmart group)
HeadquartersBrisbane, Queensland
Business ModelFranchise — pharmacist-owner operates under brand with group purchasing and marketing support
Investment RangeAUD $250,000–$600,000 (total entry cost including fit-out and stock)
Royalty Structure0% royalty on revenue
Franchise Term5-year franchise agreement
8 more fields in full report

What's in the TerryWhite Chemmart Report

Executive Intelligence Summary

TerryWhite Chemmart is one of Australia's largest branded community pharmacy networks, operating approximately 520 locations across metropolitan, suburban, and regional Australia.

Structural Economics

Observation: TerryWhite Chemmart charges no royalty fee and no marketing levy to franchisees.

Cost and Fee Architecture

The cost structure of a TerryWhite Chemmart franchise is shaped by the zero-royalty model, the high cost of dispensary and retail stock, and the labour intensity of operating a dual clinical-retail business.

Network Dynamics and Market Position

TerryWhite Chemmart occupies a mid-market community pharmacy position — trusted, professional, and locally relevant, but without the aggressive price-leading strategy of discount chains or the boutique specialisation of compounding or integrative pharmacies.

Operator Reality

The daily reality of operating a TerryWhite Chemmart pharmacy is a continuous balance between two demanding disciplines: clinical pharmacy practice and retail business management.

Profitability Structure

TerryWhite Chemmart pharmacy profitability is driven by the interaction of five variables: (1) dispensing script volume and PBS reimbursement , (2) front-of-shop retail revenue and margin , (3) professional services income , (4) supplier rebates earned on purchasing volume , and (5) the operational cost base — principally labour and rent.

Final Intelligence Assessment

TerryWhite Chemmart is a well-established community pharmacy franchise that offers a genuinely distinctive proposition in Australian franchising: strong brand recognition with zero ongoing royalty or marketing fees.

Risk Scores Preview

Financial Risk8.3 / 10

PBS reimbursement dependency and thin dispensary margins offset by zero royalty model

Structural Risk7 / 10

Mature network with strong brand but limited differentiation between locations

Operational Risk5 / 10

Regulatory compliance burden, pharmacist staffing challenges, and dual clinical-retail management

Market Risk2.5 / 10

PBS reform trajectory, supermarket/discount pharmacy competition, and online health retail growth

Legal / Compliance Risk5 / 10

Pharmacy ownership laws, PBS compliance, AHPRA registration, and controlled substance regulations

Full rationale, weighted calculation, and actionable implications available in the complete report.

Not ready for the full report? Start with a Quick Check — $29 with cost data and risk traffic lights for this brand.

Get Quick Check

Get the Full Report

$197

One-time payment. Instant access. No subscription.

Secure payment via Stripe Instant access after payment 30-day money-back guarantee

This report is included in the Complete Package ($1,995). Get this + 307 other reports + due diligence tools + negotiation training.

Best suited for

  • Prospective franchisees evaluating TerryWhite Chemmart
  • Buyers comparing multiple franchise opportunities
  • Accountants or lawyers advising franchise clients
  • Anyone conducting franchise due diligence

Why pay for this report?

  • Saves 20+ hours of independent research
  • Structured analysis you won't find in blog posts
  • Risk scoring framework used by consultants
  • Costs 0.01% of the franchise investment it protects

Brand reports are compiled from publicly available data and independent research. FranchiseInsights is not affiliated with any franchise brand. Information may not be current. Verify all data independently before making decisions. Produced under the FranchiseInsights Editorial Standard.